Upadacitinib (CAS 2050057-56-0) is a high-purity, GMP-compliant API, a potent and selective JAK1 inhibitor (ABT-494). It treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and other autoimmune diseases. Meeting USP, EP and ICH standards, it's ideal for oral extended-release tablet formulation development and commercial production
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
APIsCNCAS Number :
2050057-56-0Upadacitinib (CAS 2050057-56-0) is a high-purity, GMP-compliant API, a potent and selective JAK1 inhibitor (ABT-494). It treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and other autoimmune diseases. Meeting USP, EP and ICH standards, it's ideal for oral extended-release tablet formulation development and commercial production
Our hours
Monday to Friday
(8:30-17:30)